Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

The biotech sector is transitioning away from a framework dominated by long-term research spending toward one in which scientific progress can be directly reflected in financial valuation. As drug ...

The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: Analysts planning to participate during the Q&A portion of ...

Critical Path Institute’s® Critical Path for Alpha-1 Antitrypsin Deficiency Consortium today announced the addition of AIRNA as its newest industry partner, bringing RNA editing expertise to the ...

As previously announced, Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, is seeking ...

Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies.

If forced to choose one descriptor for the octopus, the best word may be “otherworldly.” These truly amazing marine animals ...

Most gene-editing tools are blind to context. Point them at a DNA sequence and they cut, whether that sequence sits inside a ...

Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have identified an overworked cog in ...

Lisa Taylor Ash joins Board of Directors, strengthening operational, regulatory and commercial expertise DUBLIN and LONDON, ...

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...